1 - 25 of 81 results for author:"Lynch H.T." in Literature citations
Results Customize
› Repeat search in UniProtKB (9)
| Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer Br. J. Cancer 106:2016-2024(2012) · Mapped (13) |
| Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Maia A.T., Antoniou A.C., O'Reilly M., Samarajiwa S., Dunning M., Kartsonaki C., Chin S.F., Curtis C.N., McGuffog L., Domchek S.M. et al. Breast Cancer Res. 14:R63-R63(2012) · Mapped (18) |
| Thirty-nine-year-old with familial colon cancer, and variant of undetermined significance in MSH6. Adonizio C., Gazzillo M., Knezetic J., Snyder C., Lynch H.T., Rybak C., Hall M.J., Lowstuter K., Eggington J., Morris G.J. Semin. Oncol. 39:125-131(2012) · Mapped (6) |
| Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. Finkelman B.S., Rubinstein W.S., Friedman S., Friebel T.M., Dubitsky S., Schonberger N.S., Shoretz R., Singer C.F., Blum J.L., Tung N. et al. J. Clin. Oncol. 30:1321-1328(2012) · Mapped (28) |
| Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Consortium of Investigators of Modifiers of BRCA1/2 Cancer Epidemiol. Biomarkers Prev. 21:645-657(2012) · Mapped (4) |
| Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. McGee J., Kotsopoulos J., Lubinski J., Lynch H.T., Rosen B., Tung N., Kim-Sing C., Karlan B., Foulkes W.D., Ainsworth P. et al. Obesity (Silver Spring) 20:1288-1292(2012) · Mapped (18) |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Consortium of Investigators of Modifiers of BRCA1/2 Cancer Epidemiol. Biomarkers Prev. 21:134-147(2012) · Mapped (18) |
| Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Mulligan A.M., Couch F.J., Barrowdale D., Domchek S.M., Eccles D., Nevanlinna H., Ramus S.J., Robson M., Sherman M., Spurdle A.B. et al. Breast Cancer Res. 13:R110-R110(2011) · Mapped (18) |
| Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Rebbeck T.R., Mitra N., Domchek S.M., Wan F., Friebel T.M., Tran T.V., Singer C.F., Tea M.K., Blum J.L., Tung N. et al. Cancer Res. 71:5792-5805(2011) · UniProtKB (1) |
| Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Neuhausen S.L., Brummel S., Ding Y.C., Steele L., Nathanson K.L., Domchek S., Rebbeck T.R., Singer C.F., Pfeiler G., Lynch H.T. et al. Cancer Epidemiol. Biomarkers Prev. 20:1690-1702(2011) · Mapped (25) |
| Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Im K.M., Kirchhoff T., Wang X., Green T., Chow C.Y., Vijai J., Korn J., Gaudet M.M., Fredericksen Z., Shane Pankratz V. et al. Hum. Genet. 130:685-699(2011) · Mapped (18) |
| Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Antoniou A.C., Kartsonaki C., Sinilnikova O.M., Soucy P., McGuffog L., Healey S., Lee A., Peterlongo P., Manoukian S., Peissel B. et al. Hum. Mol. Genet. 20:3304-3321(2011) · Mapped (18) |
| Upper urinary tract carcinoma in Lynch syndrome cases. Crockett D.G., Wagner D.G., Holmang S., Johansson S.L., Lynch H.T. J. Urol. 185:1627-1630(2011) · Mapped (12) |
| Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Spurdle A.B., Marquart L., McGuffog L., Healey S., Sinilnikova O., Wan F., Chen X., Beesley J., Singer C.F., Dressler A.C. et al. Cancer Epidemiol. Biomarkers Prev. 20:1032-1038(2011) · Mapped (13) |
| Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers. Metcalfe K., Lynch H.T., Ghadirian P., Tung N., Kim-Sing C., Olopade O.I., Domchek S., Eisen A., Foulkes W.D., Rosen B. et al. Breast Cancer Res. Treat. 127:287-296(2011) · Mapped (18) |
| Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Antoniou A.C., Beesley J., McGuffog L., Sinilnikova O.M., Healey S., Neuhausen S.L., Ding Y.C., Rebbeck T.R., Weitzel J.N., Lynch H.T. et al. Cancer Res. 70:9742-9754(2010) · Mapped (18) |
| Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. Gaudet M.M., Kirchhoff T., Green T., Vijai J., Korn J.M., Guiducci C., Segre A.V., McGee K., McGuffog L., Kartsonaki C. et al. PLoS Genet. 6:e1001183-e1001183(2010) · Mapped (18) |
| BRCA1 and BRCA2 families and the risk of skin cancer. Ginsburg O.M., Kim-Sing C., Foulkes W.D., Ghadirian P., Lynch H.T., Sun P., Narod S.A., Olopade O.I., Tung N., Couch F. et al. Fam. Cancer 9:489-493(2010) · Mapped (18) |
| Sex hormone regulation of survivin gene expression. Nabilsi N.H., Broaddus R.R., McCampbell A.S., Lu K.H., Lynch H.T., Chen L.M., Loose D.S. J. Endocrinol. 207:237-243(2010) · Mapped (9) |
| Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. Dennis J., Ghadirian P., Little J., Lubinski J., Gronwald J., Kim-Sing C., Foulkes W., Moller P., Lynch H.T., Neuhausen S.L. et al. Breast 19:479-483(2010) · Mapped (18) |
| Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Wang X., Pankratz V.S., Fredericksen Z., Tarrell R., Karaus M., McGuffog L., Pharaoh P.D., Ponder B.A., Dunning A.M., Peock S. et al. Hum. Mol. Genet. 19:2886-2897(2010) · Mapped (29) |
| Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers. Domchek S.M., Friebel T.M., Garber J.E., Isaacs C., Matloff E., Eeles R., Evans D.G., Rubinstein W., Singer C.F., Rubin S. et al. Breast Cancer Res. Treat. 124:195-203(2010) · Mapped (18) |
| Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Spurdle A.B., Fahey P., Chen X., McGuffog L., Easton D., Peock S., Cook M., Simard J., Rebbeck T.R., Antoniou A.C. et al. Breast Cancer Res. Treat. 122:281-285(2010) · Mapped (32) |
| Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Osorio A., Milne R.L., Pita G., Peterlongo P., Heikkinen T., Simard J., Chenevix-Trench G., Spurdle A.B., Beesley J., Chen X. et al. Br. J. Cancer 101:2048-2054(2009) · Mapped (22) |
| Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Neuhausen S.L., Brummel S., Ding Y.C., Singer C.F., Pfeiler G., Lynch H.T., Nathanson K.L., Rebbeck T.R., Garber J.E., Couch F. et al. Breast Cancer Res. 11:R76-R76(2009) · Mapped (31) |